default author photo

Dermot McGovern

Cedars Sinai Medical Center

8700 Beverly Blvd.

Los Angeles, CA 90048

United States

F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute

8700 Beverly Blvd

Los Angeles, CA 90048

United States

SCHOLARLY PAPERS

3

DOWNLOADS

186

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Allogeneic Bone Marrow Transplantation for Patients with Treatment-Refractory Crohn's Disease

Number of pages: 29 Posted: 13 Oct 2022
Fred Hutchinson Cancer Research Center - Clinical Research Division, University of Oslo - Department of Pathology, Cedars Sinai Medical Center, University of Oslo - Department of Pathology, University of Oslo - Department of Transplantation Medicine, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, University of Oslo - Oslo University Hospital, Fred Hutchinson Cancer Research Center - Clinical Research Division, Virginia Mason Medical Center, Cedars Sinai Medical Center - F. Widjaja IBIRI Institute, University of Oslo - Oslo University Hospital, University of Oslo - Department of Pathology, Fred Hutchinson Cancer Research Center - Clinical Research Division and University of Oslo - Department of Hematology
Downloads 75 (837,727)

Abstract:

Loading...

Mucosal immune chimerism, polygenic risk score, outcomes, reduced-intensity conditioning, Crohn's Disease

2.

Longitudinal Vaccine-Induced Humoral Immune Response in Cancer Patients

Number of pages: 27 Posted: 01 Oct 2021
Cedars Sinai Medical Center - Cancer Research Center for Health Equity, Cedars-Sinai Medical Center - Division of Hematology and Cellular Therapy, Cedars-Sinai The Angeles Clinic & Research Institute, Cedars-Sinai Medical Center - Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center - Division of Hematology and Cellular Therapy, University of California, Irvine, Cedars-Sinai Medical Center - Division of Medical Oncology, Cedars-Sinai Medical Center - Division of Medical Oncology, Cedars-Sinai Medical Center - Division of Hematology and Cellular Therapy, Cedars-Sinai Medical Center - Division of Medical Oncology, Cedars-Sinai Medical Center - Division of Medical Oncology, Cedars-Sinai Medical Center - Division of Medical Oncology, Cedars-Sinai Medical Center - Division of Medical Oncology, Cedars-Sinai Medical Center - Division of Medical Oncology, Cedars-Sinai The Angeles Clinic & Research Institute, Cedars-Sinai Medical Center - Division of Medical Oncology, Cedars-Sinai Medical Center - Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center - Department of Pathology and Laboratory Medicine, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars Sinai Medical Center, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Abbott Laboratories - Applied Research and Technology, Abbott Diagnostics, Abbott Diagnostics, Cedars-Sinai Medical Center - Department of Cardiology, Cedars Sinai Medical Center - Smidt Heart Institute, Cedars Sinai Medical Center - Department of Cardiology, Cedars-Sinai Medical Center - Department of Cardiology, Cedars-Sinai Medical Center - Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center - Division of Medical Oncology and Cedars Sinai Medical Center - Division of Hematology and Cellular Therapy
Downloads 58 (980,173)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Cancer, Immune Checkpoint Inhibitors, B-Cell Targeted Therapies, Humoral Immune Response, Breakthrough Infections

3.

Understanding Anti-TNF Treatment Failure: A Prospective Multi-Centre Study of Biologic Naive Patients with Active Luminal Crohn's Disease

Number of pages: 43 Posted: 15 Oct 2018
University of Exeter, Government of the United Kingdom - Royal Devon and Exeter Hospital, University of Exeter - Medical School, Government of the United Kingdom - Royal Devon and Exeter Hospital, University of Exeter, University of Exeter, University of Exeter, Government of the United Kingdom - Royal Devon and Exeter Hospital, Government of the United Kingdom - Royal Devon and Exeter Hospital, NHS Foundation Trust - London North West Healthcare NHS Trust, University of Exeter - IBD Pharmacogenetics Research Group, Government of the United Kingdom - Royal Devon and Exeter Hospital, Government of the United Kingdom - Royal Devon and Exeter Hospital, University of Exeter - IBD Pharmacogenetics Research Group, Government of the United Kingdom - NHS Greater Glasgow and Clyde, University of Southampton, Western General Hospital Edinburgh, NHS Foundation Trust - London North West Healthcare NHS Trust, NHS Foundation Trust - Cambridge University Hospitals, Hull and East Yorkshire Hospitals, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust, Government of the United Kingdom - Barts Health NHS Trust, Government of the United Kingdom - NHS Greater Glasgow and Clyde, Government of the United Kingdom - Royal Devon and Exeter Hospital, Cedars Sinai Medical Center, Independent, University of Exeter and University of Exeter - IBD Pharmacogenetics Research Group
Downloads 53 (1,031,043)

Abstract:

Loading...